期刊文献+

帕瑞昔布钠对上腹部手术术后舒芬太尼静脉镇痛效果的影响 被引量:5

Effects of Parecoxib Sodium on Sufentanil Intravenous Analgesia after Upper Abdominal Operation
下载PDF
导出
摘要 目的探讨帕瑞昔布钠应用于上腹部手术后舒芬太尼静脉自控镇痛(PCIA)效果的影响。方法选择80例ASAⅠ~Ⅱ级全麻下行上腹部手术患者,分为A组帕瑞昔布钠组,B组生理盐水组。于术毕前半小时A组静脉推注帕瑞昔布钠40 mg(用生理盐水稀释成2 mL),B组静脉推注生理盐水2mL,术毕即开始进行舒芬太尼PCIA。用视觉模拟评分法(VAS)观察两组患者术后2 d内各时点的镇痛效果;同时记录48 h舒芬总用量以及需哌替啶镇痛患者例数;平均自控镇痛(PCA)总按压次数和有效次数;记录患者满意度;两组患者术后不良反应的发生率。结果 A组患者术后1、2、4、8、12 h VAS评分低于B组;舒芬太尼用量以及PCA总按压次数及有效按压次数A组均少于B组,需哌替啶镇痛的患者数A组亦少于B组;B组恶心、呕吐发生率高于A组。结论帕瑞昔布钠联合舒芬太尼PCIA用于上腹部手术的术后镇痛安全、有效,值得在临床推广应用。 Objective To discuss the effect of parecoxib sodium on sufentanil intravenous analgesia after upper abdominal operation.Methods 80 cases of ASA Ⅰ-Ⅱ abdominal operation patients were divided into group A(parecoxib group) and group B(saline group).In half an hour before the operation,group A was intravenously injected parecoxib sodium 40 mg(diluted with saline into 2 mL),group B was intravenously injected saline 2 mL.All patients began sufentanil intravenous analgesia at the end of operation.We observed the visual analog scale(VAS) grade of the two groups′ patients in several time points in 2 days after operation,the total dosage of sufentanil and the patient numbers who needed analgesia with dolantin,the average click times and effective times,the satisfaction of patients and the incidence of untoward effect of the two groups were recorded.Results Group A VAS grades after operation were lower than B group at 1,2,4,8 and 12h;and the dosage of sufentanil,the total click times of PCA and the effective times,the number of patients who need dolandin,nausea and vomiting incidence of group A were also lower than group B.Conclusion Using parecoxib sodium in combination with sufentanil intravenous analgesia after upper abdominal operation is safe and effective,worth of popularization in clinic.
作者 熊先锋
出处 《医学综述》 2012年第6期939-941,共3页 Medical Recapitulate
关键词 舒芬太尼 帕瑞昔布钠 术后镇痛 Sufentanil Parecoxib sodium Postoperative analgesia
  • 相关文献

参考文献11

  • 1Law Rence DD,Julior.William TL,et al.Multi modal analgesia fortotal knee arthroplasty[J].J Arthro,2008,123(4):502-508.
  • 2Power I,Barratt S.Analgesic agents for the postoperative period.Nonopioids[J].Surg Clin North Am,1999,79(2):275-295.
  • 3Tong D,Chung F.Postoperative pain control in ambulatory surgery[J].Surg Clin North Am,1999,79(2):401-430.
  • 4Lipsky LP,Abramson SB,Crofford L,et al.The classification of cy-clooxygenase inhibitors[J].J Rheumatol,1998,25(12):2298-2303.
  • 5吴新民,岳云,张利萍,王俊科,艾登滨,于布为,薛张纲,黄文起.术后镇痛中帕瑞昔布钠对吗啡用量的节俭作用和安全性—前瞻性、多中心、随机、双盲、安慰剂对照、平行分组研究[J].中华麻醉学杂志,2007,27(1):7-10. 被引量:367
  • 6Langford RM,Joshi GP,Gan TJ,et al.Reduction in opioid-relatedadverse events and improvement in function with parecoxib fol-lowed by valdecoxib treatment after non-cardiac surgery:a random-ized,double-blind,placebo-controlled,parallel-group trial[J].ClinDrug Investig,2009,29(9):577-590.
  • 7Tang J,Li S,White PF,et al.Effect of parecoxib,a novel intrave-nous cyclooxygenase type-2 inhibitor,on the postoperative opioidrequirement and quality of pain control[J].Anesthesiology,2002,96(6):1305-1309.
  • 8Schug SA,Joshi GP,Camu F,et al.Cardiovascular safety of the cy-clooxygenase-2 selective inhibitors parecoxib and valdecoxib in thepostoperative setting:an analysis of integrated data[J].AnesthAnalg,2009,108(1):299-307.
  • 9Koppert W,Frotsch K,Huzurudin N,et al.The effects of paraceta-mol and parecoxib on kidney function in elderly patients undergoingorthopedic surgery[J].Anesth Analg,2006,103(5):1170-1176.
  • 10Cheer SM,Goa KL.Parecoxib(parecoxib sodium)[J].Drugs,2001,61(8):1133-1141.

二级参考文献24

  • 1Bensen WG, Fiechtner JJ, McMillen JI, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc, 1999; 74:1095-1105.
  • 2Gierse JK, McDonald JJ, Hauser SD, et al. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors, J Biol Chem, 1996, 271(26): 15810-15814.
  • 3Apfelbaum JL, Desjardins PJ, Brown MT, et al. Multiple-day efficacy ofparecoxib sodium treatment in postoperative bunionectomy pain. Clin JPain, 2008, 24(9): 784-792.
  • 4Michael C, Artur J, Kotarski J, et al. Parecoxib sodium administered over several days reducespain after gynecologic surgery via laparotomy. ] Clin Anesth, 2007, 19:448-455.
  • 5Viscusi ER, Gimbel JS, Halder AM, et al. A multiple-day regimen of parecoxib sodium 20 mg twice daily provides pain relief after total hip arthroplasty. Anesth Analg, 2008, 107(2): 652-660.
  • 6Tang J, Li S, White PF, et al. Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. Anesthesiology, 2002, 96(6): 1305-1309.
  • 7Malan TP, Marsh G, Hakki SI, et al. Parecoxib sodium, a parenteral cyclooxygenase-selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty, Anesthesiology, 2003, 98: 950-957.
  • 8Jirarattanaphochai K, Thienthong S, Sriraj W, et al. Effect of parecoxib on postoperative pain after lumbar spine surgery. Spine, 2008, 33: 132-139.
  • 9Hubbard RC, Naumann TM, Traylor L, et al. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth, 2003, 90(2): 166-172.
  • 10Barton SF, Langeland FF, Snabes MC, et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute post-operative pain following gynecologic laparotomy surgery. Anesthesiology, 2002, 97: 306-314.

共引文献392

同被引文献33

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部